ENDEMIC GOITER WITH THE DISEASE TERRITORIES ACCORDING TO SPREAD

dc.contributor.author	Usmanova N. Y
dc.contributor.author	Berdikulova D.M
dc.contributor.author	Abdukaxarova M.F
dc.contributor.author	Khamzaeva N. T
dc.date.accessioned	2025-12-31T15:40:34Z
dc.date.issued	2025-02-03
dc.description.abstract	In the general population, nodular goiter is detected in 3-5% of patients during palpation of the thyroid gland, and in 20-35% during screening ultrasound (US) and tissue autopsy. There are many etiological factors for the development of nodular non-toxic goiter (goitrogens, according to epidemiological studies conducted by the Federal Endocrinological Sciences center, there are no regions in the Russian Federation where the population is not at risk of developing iodine deficiency diseases.
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbph/article/view/4926
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/49932
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbph/article/view/4926/4168
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Public Health; Vol. 43 (2025): WBPH; 6-11
dc.source	2749-3644
dc.subject	screening
dc.subject	Endocrinological
dc.subject	deficiency
dc.title	ENDEMIC GOITER WITH THE DISEASE TERRITORIES ACCORDING TO SPREAD
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: y_2025_endemic_goiter_with_the_disease_territor.pdf
item.page.filesection.size: 393.86 KB
item.page.filesection.format: Adobe Portable Document Format